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A b s t r a c t  
Over the past few decades, there has been increased interest for innovative drug delivery system to 
improve the safety, efficacy and patient compliance, thereby increasing the product patent life cycle. 
In  the  recent  years,  many of  the  pharmaceutical  groups  are  focusing  their  research  on  rapid 
dissolving  technology. Fast dissolving oral films are the most advanced form of oral solid dosage 
form due to more flexibility and comfort. It improve the efficacy of APIs by dissolving within minute in 
oral cavity after the contact with less saliva as compared to fast dissolving tablets, without chewing 
and no need of water for administration. These films have a potential to deliver the drug systemically 
through intra-gastric, sublingual or buccal route of administration and also has been used for local 
action. This type of technology offer a convenient way of dosing medication, not to special 
population groups like pediatric, geriatric, bedridden patients, mentally ill patients, but also to the 
general population. Fast dissolving oral films are found to be satisfactory in many situations like 
allergic conditions, cold and cough, sore throat, nausea, pain, mouth ulcers, CNS disorders and 
CVS disorders. Oral film includes various ingredients for its formulation which includes polymers, 
active pharmaceutical ingredient, film stabilizing agents, plasticizers, sweeteners, flavours, colors, 
saliva stimulating agents, surfactants etc. The present review reflects  information regarding  
formulation  ingredients,  technologies  and  evaluation  tests  employed  in  the  preparation  of  fast 
dissolving oral films. However, for future growth point of view the fast dissolving oral films sector is 
well-positioned. It seems that the value of the overall oral thin films market will grow significantly. 
Keywords: Fast dissolving oral films, Oral Mucosa, Disintegration, Hydrophilic polymers, Innovative 
drug delivery, Patented Technologies. 
Introduction 
Fast dissolving oral films were first introduced in the market as 
breath fresheners and personal care products such as dental strips 
and soap strips. However, they are introduced in the United States 
and European pharmaceutical markets for therapeutic effect [1]. 
Fast dissolving oral films are most advance form of solid dosage 
form due to various reasons like flexibility, improved efficacy of API 
(Active Pharmaceutical Ingredient), dissolution and disintegration 
within 1 minute with the help of less amount of saliva as compared 
to dissolving tablet. Thin films have the potential to allow the 
development of sensitive drug targets that may otherwise not be 
possible in tablets or liquid formulations [2]. Oral ingestion is the 
most common and oldest route of administration which consists of 
tablets, capsules, etc. But this type of ingestion is not suitable for 
geriatric and pediatric patient suffering from the dysphasia, 
bedridden and non- compliant patients due to the fear of chocking 
[3]. So, to overcome this disadvantage bioadhesive mucosal 
dosage forms have been introduced which includes adhesive 
tablets, gels, ointments, patches and then in 1970s polymeric films 
were introduced also known as oral thin films or fast dissolving 
films or mouth dissolving films or oro-dispersible films or quick 
disintegrating films and melt in mouth dosage form which was 
based on the technology of transdermal patches [4]. Today, these 
are proven to be acceptable for OTC (Over the Counter) 
medications and are in the early to mid- development stages for 
prescription drug. Zulpenz is the first oral soluble disintegrating film 
approved by the FDA as a prescriptions medication [5].These 
consists of thin oral films which get absorbed in the buccal cavity 
with the help of saliva, as hydrating agent without requirement of 
water and give their effect through pre-gastric absorption from 
mouth, pharynx and oesophagus as the saliva passes down into 
the stomach [6]. 
Physiochemical properties of oral mucosa 
Permeability coefficient of a drug is the measure of ease with which 
the drug can permeate a membrane [7]. Order of permeability is 
intestine> buccal mucosa> skin [8]. This permeability ranking is 
based upon the relative thickness and degree of keratinization. 
Permeability of buccal mucosa is 4-4000 times greater than that 
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of skin. Due to less permeability of buccal mucosa than the 
intestine some permeability enhancer has been extensively 
developed in the buccal drug delivery system like [9];  
Aprotinin 
23-Lauryl ether 
Benzalkonium chloride 
Dextran sulphate  
Sodium taurodeoxycholate 
Hence buccal delivery serves as an excellent platform for 
absorption of drug. Absorption of oral film takes place either 
through transcellular route (intracellular route) and paracellular 
route (intercellular route) [7, 8].  
Oral mucosa consists of three layers [7]: 
Stratified squamous epithelium (outermost layer) 
Lamina propria (intermediate layer) 
Submucosa (innermost layer) 
Epethelium of oral mucosa is 40-50 cell layers thick which is 
composed of intercellular ground substance called mucus which 
consists of proteins and carbohydrates. Mucosal thickness of hard 
and soft palates, the floor of the mouth, the ventral tongue and the 
gingival varies from 100-200 um. Submucosal layer secrets gel like 
secretion known as mucous which consists of 1-5% of water 
insoluble glycoprotein, 90-99% water and other components like 
proteins, enzymes, electrolytes and nucleic acids in very small 
quantities and this composition varies depending upon the origin of 
secretion in the body [7, 8]. 
Function of mucous:   
Maintains hydrating conditions of oral cavity 
Provides adequate lubrication  
Provides concentrated protective molecules such as secretory 
immunoglobulins and also reduces attachment of micro-organisms.     
Salivary gland consists of lobules of cell which secrete saliva and 
parotid through the salivary duct near the teeth submandibular and 
the sublingual ducts. Minor salivary glands present in the lips, 
buccal mucosa and in lining of the mouth and the throat. Total 
amount of saliva secreted per minute is 1-2 ml [3]. Saliva consists 
of water, mineral salts, salivary amylase (enzyme), mucus, 
lysozyme, immunoglobulins and blood clotting factors [10]. Saliva 
and salivary mucin contribute to the barrier properties of oral 
mucosa. Negative charge of mucin contains sulphydryl group and 
salic acid responsible for the muco-adhesive phenomenon [9].  
Ideal characteristics of oral films  
Should have pleasant taste. 
Dose upto 40mg can be incorporated. 
Drug should be stable to moisture overtime and soluble in saliva. 
Should exhibit suitable tensile strength. 
Should not stick to the packing material and fingers. 
Should be ionized at pH of oral cavity. 
Should be able to permeate the oral mucosal tissue. 
Should not be bitter and have quick onset of action. 
Drug with smaller and moderate molecular weight are preferable. 
Drug should have high first pass metabolism [4, 11]. 
Advantages of oral films 
Convenient dosing.  
No water requirement. 
No risk of chocking. 
Enhanced stability. 
Ease of administration. 
Bypass of the GIT improves its bioavailability. 
Due to low dose, low side effects. 
Good mouth feel. 
Rapid onset of action in case of mouth sickness and allergic 
attacks like asthma. 
Controlled release of drug facilitates the rate and extent of 
absorption.  
Does not interfere with normal function like talking, drinking etc. 
Delivery of those API is possible which are at high risk of 
degradation in the gastrointestinal tract [9, 12]. 
Disadvantages of oral films  
Packing requires special equipment. So, difficult to pack. 
Not suitable for drugs which irritate and are unstable at buccal pH. 
Only small dose of drug can be administered. 
Hygroscopic in nature. So, longer preservation is difficult. 
Drugs which are absorbed only by passive diffusion can be 
administered by this route.  
Restriction of eating and drinking for sometime after consumption 
of oral film. 
Method for preparation is expensive as compared to oral dissolving 
tablets [7, 13, 14]. 
Formulation of fast dissolving oral films 
Excipients used in oral films are given below as per their 
categories. All excipients used in formulation should be chemically 
inert and approved for use in the formulation of oral films. 
According to the film forming material characteristics, the 
manufacture of the dosage forms can present different critical 
issues. Common problems are caused by foaming during the film 
formation due to the heating of the material or solvent evaporation, 
the flaking during the slitting and the cracking in the cutting phase 
[15]. 
     Table 1: Composition of oral thin films [16, 17] 
S. No. Name of the excipient Quantity
1 Drug 5-30%
2 Film  forming  polymer 40-50%
3 Plasticizer 0-20%
4 Saliva stimulating agent 2-6%
5 Sweetening  agent 3-6%
6 Surfactant Q.S
7 Flavouring  agent Q.S.
8 Colouring  agent Q.S.
Active pharmaceutical ingredient  
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The selection of API depends upon its potency, dose and 
therapeutic efficacy. Most suitable API for ODF includes antiulcers, 
antiasthmatics, antitussive, antihistaminic, antiepileptic, 
expectorants, antianginal antiemetic, neuroleptics, cardiovascular 
agents, analgesics, antiallergic, antiepileptic, anxiolytics, sedatives, 
hypnotics, diuretics, anti-parkinsonism agents, anti-bacterial agents 
and drugs used for erectile dysfunction, anti-alzheimers, 
expectorants and anitussive [18]. 
 
Table 2: List of some marketed products along with their API [19] 
S. No. Drugs  API Use 
1 Benadryl® Diphenylhydramine HCL (12.5mg or 25mg) Antiallergic 
2 Suppress® Menthol (2.5mg) Cough suppressants
3 Klonopin Wafers Clonazepam (0.125mg,0.25mg,0.5mg, 1mg or 2mg) In anxiety 
4 Theraflu® Dextromethorphan HBR (15 mg) Anti allergic 
5 Orajel® Menthol/pectin (2mg/30mg) Mouth ulcer 
6 Gas-X Simethicone (62.5mg) Anti flatuating 
7 Chloraseptic® Benzocaine/menthol (3mg/3mg) Sore throat 
8 Triaminic® Diphenylhydramine HCL (12.5mg) Anti allergic 
 
Film forming polymer  
The selection of polymer is one of the most important and critical 
parameter for the successful development of oral films because of 
their tensile strength which depends upon the type and amount of 
polymer used. At least 45% w/w of polymer should be present 
based on the total weight of dry film but typically 60-65% w/w of 
polymer is preferred to obtain desired properties [20]. The 
polymers can be used alone or in combination to obtain the desired 
film properties. The film obtained should be quiet enough so that 
there won't be any damage while handling or during transportation 
[21]. 
Ideal properties of the film forming polymers  
The polymer employed should be non-toxic, non-irritant. 
It should be devoid of leachable impurities. 
It should have good wetting and spreading properties. 
The polymer should exhibit sufficient peel, shear and tensile 
strengths. 
The polymer should be readily available and should not be very 
expensive. 
It should have good shelf life. 
It should not aid in cause secondary infections in the oral mucosa/ 
dental region. 
It should have a good mouth feel property. 
It would be ideal to have a polymer that would have local enzyme 
inhibition action along with penetration enhancing property. 
It should not be an obstacle in the disintegration time [22, 23]. 
 
                               Table 3: List of polymers used in oral thin films [20, 24] 
Group Class Example
Natural ? Carbohydrate 
 
Pullalan, pectin, sodium alginate, maltodextrin, Sodium starch glycolate 
(SSG) 
? Proteins Gelatin
? Resin Polymerized rosin (novel film former)
Synthetic ? Cellulose derivatives 
 
 
 
Hydroxy propylmethycellulose (E3, E5, E15, K3, K15, K50), Methylcellulose 
(A3, A6, A15), Carboxy methylcellulose secekol- 30, Sodium carboxymethyl 
cellulose, Microcrystaline cellulose, Croscarmellose sodium (CCS).  
? Vinyl polymer Poly vinyl pyrrolidone (K-90, K-30), Poly vinyl alcohol, poly ethylene oxide
? Acrylic polymer Eudragit (RD-100, 9, 10, 11, 12 and RL-100)
 
Natural polymers 
Pullalan 
It is a neutral glucan, with a chemical structure somewhat 
depending upon carbon source, producing micro-organism like 
Aureobasidium pullalans and fermentation conditions [25]. The 
basic structure is a linear đ- glucan one, made from three glucose 
units linked đ-(1,4) in maltotriose units which are linked in a đ-(1,6) 
way. The three glucose units in maltotriose are connected by an đ- 
(1,4) glycosidic bond, whereas consecutive maltotriose units are 
connected to each other by an đ-(1,6) glycosidic bond. The regular 
alternation of (1 ā 4) and (1 ā 6) bonds results in two distinctive 
properties of structural flexibility and enhanced solubility [20]. 
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It is soluble in alcohol, ether, benzene and chloroform. 
Mechanical properties can be improved by the addition of 
plasticizer such as dibutyl sebacate (DBS). 
It has an excellent anti-oxidation property and high softening point 
[20, 23].  
 
                 Figure 5: Structure of Maltodextrins 
Starch 
Biopolymer starch is composed of glucose units and having two 
main constituents are, amylose and amylopectin. Amylose 
constituent is a linear one, having long chain of đ-D glucose units 
linked together by đ-1,4 glycoside linkages and only  slightly 
branched. The amylopectin constitutes đ-1,4 linkages of glucose 
units, interlinked by đ- 1,6 linkages and having a branched 
structure. 
 
 
  Figure 6: Structure of Starch 
 
Recently, Hu et al have developed starch films from oxidized 
potato starch (OPS) with glycerol as a plasticizer. For example, 
pre-gelatinized starch includes lycoat (NG73), modified starch, 
amylase rich starch [20].                                                                                                                 
Salient features 
It is insoluble in cold water and ethanol. 
It swells in water by about 5 to10% at 37 . 
It decomposes at 250 .  
2% aqueous dispersion of starch provides 13 mPa s viscosity [6, 
11]. 
Synthetic polymers 
Hydroxy propylmethyl cellulose  
HPMC polymer has a high glass transition temperature and is 
classified according to the content of substituentÊs and its viscosity 
which affects the solubility-temperature relationship. Lower grades 
of HPMC like Methocel E3, E5, and E15 are particularly used for 
film formation because of their low viscosity [7]. 
 
 
     Figure 7: Structure of Hydroxy propylmethycellulose 
Salient features 
Soluble in cold water, forming a viscous colloidal solution. 
Insoluble in chloroform and ethanol [11]. 
Hydroxypropyl cellulose 
Hydroxypropyl cellulose is partially subsituted polyether of cellulose 
[22].  
 
 
Figure 8: Structure of Hydroxypropylcellulose 
Salient features 
5% w/w is generally used for film coating. 
It is freely in water, in many cold and hot polar organic solvents. 
Molecular weight is 50,000-1250000 kDa [11, 20]. 
Polyethylene glycol 
PEG is produced by the interaction of ethylene oxide with water, 
ethylene glycol or ethylene glycol oligomers [23]. The starting 
materials used for synthesis of PEG polymers with low Poly 
dispersity index (PDI) (narrow molecular weight distribution) are 
Ethylene glycol and its oligomers. Reactions catalyzed by anionic 
polymerization result in PEGs with low PDI [27]. 
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Figure 9: Structure of Polyethylene glycol 
Salient features 
It is soluble in water and in various organic solvents like 
acetonitrile, chloroform and methylene chloride. 
Molecular weight of PEG ranges from 100,000 to 8,000,000. 
Melting point is 65-70  . 
pH ranges from 8-10 [11, 20, 22]. 
Kollicoat  
Kollicoat is a new pharmaceutical excipient that was developed as 
a coating polymer for controlled release tablets. It is a polyvinyl 
alcohol-polyethylene glycol graft copolymer whose polyvinyl 
alcohol moiety provides good film forming properties and 
polyethylene glycol part acts as an internal plasticizer leading to 
good flexibility properties [20]. 
 
 
                  Figure 10: Structure of Kollicoat 
Salient feature 
It is used to form transparent film [11]. 
Polyvinyl alcohol  
It is synthesized by the polymerization of vinyl acetate to polyvinyl 
acetate which is then hydrolysed to get PVA. The crystallizability 
and solubility of PVA is affected by the extent of hydrolysis and 
content of acetate group present in PVA [27]. 
 
 
                         Figure 11: Structure of Polyvinyl alcohol 
 
Salient feature 
It has melting point of 230  and 180-190  for fully hydrolysed 
and partially hydrolysed grades, respectively [27, 28]. 
Polyvinyl pyrrolidone 
It is a branched and more complicated polymer than linear 
polymer, though it lies in a two-dimensional plane. It is also known 
as polyvidone. It is synthesized by polymerization of 
vinylpyrrolidone in water or isopropanol [27]. 
 
Figure 12: Structure of Polyvinyl pyrrolidone 
Salient feature 
In dry form it readily absorbs upto 40% of its weight in atmospheric 
water [29]. 
Gum Carrageenan 
These sulphated polysaccharides are extracted from cell wall of 
various red seaweeds belonging to family Rhodophyceae. The 
main sources for carrageenan are the Chondrus crispus, 
Eucheuma cottonii and Eucheuma spinosum species [22]. 
 
 
Figure 13: Structure of Gum Carrageenan 
Salient features 
Films made from carrageenan were found to be less opaque than 
those obtained from starch [22]. 
Chitosan 
Water soluble derivatives of chitosan have been synthesized by 
chemical modification like carboxymethylation of chitosan results in 
formation of N-carboxymethylchitosan which is soluble in wide 
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range of pH. So, their main drawback related to solubility can be 
overcome by this method. Chemical modification results in the 
formation of hydrophilic chitin which has more affinity to water or 
organic solvents [27].   
 
Table 4: Few examples of drugs with type of polymer used [11, 26, 30] 
Oral films Polymer used
Amlodipin Besylate Sodium alginate
 HPMC-E5
Famotidine  HPMC, sodium carboxy methyl cellulose, PVA 
Ondansetron hydrochloride Polyvinylalcohol, polyvinyle pyrrolidone, Carbopol E5 
Glipizide HPMC, sodium carboxymethlcellulose, carbopol-934P and 
Domperidone PVA
Valdecoxib HPMC, Eudragit EPO
Cetrizine hydrochloride Pullulan gum
Verapamil HPMC-E6, Maltodextrin
Levocitrazine dihydrochloride Eudragit EPO, HPMC E5 LV, PVA
 
Plasticizer  
Plasticizer used in the formulation should be compatible with the 
type of polymer used as it reduces the glass transition temperature 
and improves flow of the polymer. So, it helps to improve the 
flexibility of the strip and reduces the brittleness of the strip [31]. It 
is also reported that the use of particular plasticizer also affect the 
absorption rate of the drug. Various defects associated with the 
inappropriate use of the plasticizer are cracking, blooming, pilling 
and splitting of the strip [32]. Plasticizer significantly improves the 
strip properties by reducing the glass transition temperature of the 
polymer in the range of 40-60  for non-aqueous solvent system 
and below 75  for aqueous system. 
Different types of polymers which get plasticized with different 
polymers like [22]: 
Cellulosic hydrophillic polymers were easily plasticized with hyroxyl 
containing plasticizers like PEG, propylene glycol, glycerol and 
polyols. 
Less hydrophillic cellulosic polymers were plasticized with esters of 
citric acid and phthalic acid. 
Polymer like polyvinyl alcohol easily gets plasticized with glycerol. 
Both hypromellose as well as polyvinyl alcohol films get plasticized 
with diethylene glycol. 
                           
Table 5: Advantages of plasticizers over other plasticizers [22] 
Plasticizer Better than Reason
Malic acid Citric acid, 
Oleic acid, 
Tartaric acid 
As it does not crystallized out when films were dried
PEG-300 
(low molecular weight) 
PEG 
(High molecular weight) 
As they formed visually superior transparent films and had 
low water vapour permeation rate  
Sorbitol  Mannitol  As it does not crystallized out when films are dried [31]
                                   Table 6: Few examples of drugs with the type of plasticizer used [20] 
Oral films Plasticizer used
Montelukast sodium Glycerine
Ropinirole hydrochloride PEG-400
Triclosan Propylene glycol
Sertraline  Propylene glycol or PEG-400
Metaclopramide hydrochloride Glycerol
Telmisartan  Propylene glycol
Dicyclomine hydrochloride PEG-400
Tianeptine sodium PEG
Amlodipine besylate Glycerol
Livocitrazine dihydrochloride Glyerine, dibutyle phthalate
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Saliva stimulating agent 
The purpose of these agents is to increase the production of saliva 
that would helps in the faster disintegration of the oral thin film. 
Citric acid, malic acid, lactic acid, ascorbic acid ad tartaric acid 
used to stimulate salivary secretions. These agents can be used 
alone or in combination between 2 to 6 % w/w of weight of the strip 
[6, 18].  
Flavouring agent 
Any flavor which is USFDA approved can be used to mask the 
bitter taste of the formulation. These agents can be selected from 
the synthetic flavor oils, oleo resins. Extract derived from various 
parts of the plants like leaves, fruit and flowers. The amount of 
flavor to be used depends upon the type of flavor used. Flavors 
that can be added are essential oils like menthol, intense mints like 
peppermint, sweet mint, spearmint, wintergreen, cinnamon, clove, 
sour fruit flavor such as lemon, orange or sweet confectionary 
flavors such as vanillin, chocolate. They can be used alone or in 
combination [18, 33]. 
Sweetening agents 
Both natural and synthetic sweetners are used to improve 
palatability of the mouth dissolving formulations [34]. 
 
        Table 7- Types of sweetening agents [16, 18] 
Natural Synthetic 
Sucrose  Mannitol First generation:            Saccharin 
Dextrose                                 Sorbitol                                      Cyclamate 
Fructose                                      Aspartame  
Glucose Second generation:       Acesulfame-K 
Liquid glucose                                                          Sucralose 
Isomaltose                                                                 Alitame and Neotame    
 
Colouring agents 
Various colouring agents used are FD & C colours, EU colours, 
natural colours and custom Pantone-matched colours. FD&C 
approved colours are used in the concentration not exceeding 1% 
w/w in the manufacturing of oral thin films, such as titanium oxide, 
silicon dioxide, zinc dioxide etc. [34, 35]. 
Surfactant 
Surfactant as solubilizing or wetting agent in the formulation so that 
film get dissolved within few seconds and releases active 
ingredient to produce an effect. Some commonly used surfactants 
are sodium lauryl sulfate, benzalkonium chloride, tweens etc. 
Palaxamer 407 is the most important surfactant used in oral thin 
films [34, 35]. 
Manufacturing of fast dissolving oral films 
One or combination of following methods can be used for the 
preparation of fast dissolving oral films: 
3.1. Solvent casting method 
3.2. Semisolid casting method 
3.3. Hot melt extrusion method 
3.4. Solid dispersion extrusion 
3.5. Rolling method 
Solvent casting method 
In this method, prepared solution is poured into the petri dishes 
and covered with the inverted funnels to allow the evaporation of 
solvents. These are kept at 20-25  for 24-48hrs depending upon 
solvent system used. Patches obtained are 15-20mm in diameter, 
0.2-0.3mm thick and are carefully pull out from the petri dishes [36, 
37, 38, 39, 40]. 
Water soluble ingredients are mixed at 60  by stirring at 1000 
rpm 
Results in viscous solution 
Addition of polymers in above solution by using high shear process 
Addition of drug 
Vaccum is applied for the removal of entrapped air 
Pour the solution in a glass mould 
Dry in oven at 40-50  
Cut into pieces of desired size 
Advantages 
Great uniformity of thickness 
Great clarity then extrusion 
More flexibility 
Better physical properties 
Finished film thickness is 12-100um 
Disadvantages 
Polymer must be soluble in a volatile solvent or water 
Viscosity should be formed 
Semisolid casting method 
In this method, acid insoluble polymer and film forming polymer 
ratio should be 1:4. The films thickness formed by this method is 
about 0.015-0.05 inches [39, 40, 41]. 
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Prepare a solution of water soluble film forming polymer 
Prepared solution is added to the solution of acid insoluble 
polymer, prepared in ammonium or sodium hydroxide like cellulose 
acetate phthalate, cellulose acetate butyrate. 
Appropriate amount of plasticizer is added to obtain a gel mass 
Gel mass is casted into the film or ribbon using heat controlled 
drums 
Mixture is degassed under vacuum 
 
Bubble free solution is coated on non-treated casting film 
Coated film is dried in aeration drying oven and cut into desired 
shape and size 
Hot melt extrusion method 
The processing temperatures should be 80  in 1st zone, 115  in 
2nd zone, 100  in 3rd zone and 65  in 4th zone. The screw 
speed should set at 15 rpm to set the granules inside the extruder 
for approximately 3-4 min. [25] 
Drug and polymer are blended in sigma blade mixer for 10 min. 
Plasticizer is added slowly 
Granulation of mixture in the presence of anti-sticking agent 
Granules are stored overnight and sieved through 250um sieve 
Dried granules are fed into the extrude 
Processing is done for 3-4 min. at temperature as mentioned 
above 
Extudate is pressed at temperature 65  to obtain a film of 
thickness 200 um 
Advantages 
Improved  bioavailability of  poorly soluble compounds 
Cost effective process with reduced production time and reduced 
number of unit operation 
Capability of sustained, modified and targeted release  
Better content uniformity 
Have stability at varying  pH and moisture levels 
Disadvantages 
Thermal process. So, requires drug and polymer stability 
Require high power input 
Binders with low melting point are at the risk of melting or softening 
of the binder during handling and storage of the agglomerates 
Binders with high melting point require high melting temperatures 
and can contribute to volatility problems especially for heat labile 
materials 
Solid dispersion extrusion  
This method involves dispersion of one or more active ingredients 
in an inert carrier in a solid state in the presence of amorphous 
hydrophilic polymers [42]. 
Immiscible drug is dissolved in suitable solvent 
Solid dispersions are prepared by incorporating above solution into 
melted polyethylene glycol: below 70  
Finally dispersions are shaped into the films by means of dies 
Precaution while preparing by this method  
Suitable solvent should be selected while dissolving a drug 
otherwise polymorphic form of drug may get precipitated in the 
solid dispersion. 
Rolling method  
In this solution or suspension containing drug is rolled on a carrier, 
solvent used is water or mixture of water and alcohol 
Film is dried on a roller and cut into the desired shape [38, 39, 43, 
44] 
Patented technologies of fast dissolving oral films 
XGel 
XGel film technology is developed by BioProgress which causes a 
revolution in the product offerings and manufacturing methods 
which is now available to the pharmaceutical industry. These films 
may be coloured or printed during manufacture for branding and 
coding which is quite helpful in product identification and also 
developed for non-ingestible applications such as cosmetic, 
ostomy pouches, sanitary and healthcare pouches [45]. These films 
enhance the stability of product. [46] 
Soluleaves 
In this technology, the film on coming in contact with saliva 
releases its active ingredients, during this film adhere to the 
mucous membrane in order to release the drug slowly in 15 min. 
This method is useful for those who have difficulty in swallowing 
conventional tablets [45]. This technology is applied to flavoured 
products such as mouth fresheners, confectionery and vitamins 
[46] 
Wafertab 
Wafertab is a drug delivery system which incorporates 
pharmaceutically active ingredients into an ingestible film strip. 
When film came in contact with saliva it provides rapid dissolution 
and release of active ingredient [47]. The Wafertab film strip can 
also be flavoured for additionally improved taste masking. The 
active ingredient is integrated into the body of a fused. 
Foamburst 
Foamburst is a new patent granted in September 2004 which is for 
capsules made of formed film. During production an inert gas is 
blown into the film, results in a film with honeycomb structure as a 
capsule which dissolve rapidly and causing a melt-in-the mouth 
sensation. The void in the film may be gas-filled, empty or filled 
with other materials to produce specific taste burst characteristics 
or deliver active drugs [47]. 
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Micap 
In 2004 Micap plc signed an agreement to combine its expertise in 
micro encapsulation technology with the BioProgress water soluble 
films. Their main aim is to provide new delivery mechanisms for the 
$1.4bn global market for smoking cessation products (SCPs) [46].  
Rapid film™ 
It is a novel thin film technology developed by Applied Pharma 
Research (APR), a leading Swiss R&D company whose main focus 
is innovative drug delivery, in conjugation with Labtec GmbH. Dr. 
Paulo Galfetti, Head of Licensing & Business Development states 
that this technology is of great importance when rapid onset of 
action is required. Galfetti advices, this technology can be used 
with poorly soluble drugs. [48] Rapid film is a thin film containing 
drug with area of 1-10 cm sq. Disintegration occurs completely 
within 20 seconds. For example: Donepezil Rapidfilm®, 
Olanzapine Rapidfilm®. [49]  
 
                                                Table no. 8: Some patents on oral thin films 
Country Patent Number Title Inventors 
US      20110305768A1 Quick dissolving oral thin film for targeted delivery of 
therapeutic agents 
Hai-Quan Mao et al [50]
WO    2012103464A2 Oral thin film vaccine preparation Brian Pulliam [51]
WO   2013085224A1 Bitter taste masked oral thin film formulation of Sildenafil 
citrate 
Dae-Kun Song et al [52]
US   6177096B1 Water soluble film for oral administration with instant 
wettability 
Horst Georg Zerbe et al [53]
EP   1680079A2 Rapidly disintegrating films for delivery of pharmaceutical 
and cosmetic agents.  
Scott D Bamhart et al [54]
EP   2509631A4 Ph sensitive compounds in taste masking within oral thin 
film strips 
A Mark Schobel et al [55]
WO   2012053006A2 Improved oral fast dissolving films comprising 
combination of polymers and method of preparation 
thereof 
Rajesh Jain et al [56]
 
US   6596298B2 Fast dissolving orally consumable films Sau-Hung Spence Leung et al [57]
WO   2014183054A1 Thin film with high load of active ingredient Eric Allen et al [58]
US   7579019B2 Pharmaceutical carrier device suitable for delivery of 
pharmaceutical compounds to mucosal surface 
Tapolsky et al [59]
 
Previous work done on fast dissolving oral films 
Deepthi et al in 2014, formulated and evaluated fast dissolving oral 
films of Zolmitriptan by solvent casting method. This film of 
zolmitriptan was evaluated using sodium alginate, xantham gum, 
sodium starch glycolate and guar gum at different concentrations 
on the basis of flexibility, tensile strength and stickiness of the film. 
The F5 formulation showed 98.5% of drug release within 6 minutes 
which was desired for fast absorption. This was indicated that the 
formulation was stable because there was no degradation of the 
film at high temperature and humidity conditions [60]. 
 Farhana Sultana et al in 2013, prepared and evaluated fast 
dissolving oral thin films of caffeine anhydrous using HPMC-2910 
(15 cps), sodium alginate and kollicoat IR white in various 
concentrations. In-vitro studies have shown that film prepared by 
using kollicoat IR white were more porous and its disintegration 
time was found to be 12 sec. and cumulative % release was 
99.89% within 240 seconds. Films prepared by using HPMC have 
shown its disintegration time of 13sec. and its cumulative % 
release was 100% within 120 sec. So, film prepared by using 
HPMC were found to be more flexible, smooth and have shown 
faster release of drug within short time [61].   
C.L. Bhingare et al in 2013, formulated and evaluated mouth 
dissolving films of Zolpidem tartrate by exploring the combination of 
polymers, hydroxypropyl cellulose (EF-P) with hydroxymethyl 
cellulose K-15 by solvent casting method. HPMC is used in the 
ratio (1:1 and 2:1) in combination with HPC. The formulation F4 
have uniformity in weight with thickness of 0.930 mm, drug content 
of 98.3% and 100% drug release within 6 minutes. Hence this 
batch could be used for incessant drug release, enhanced rate of 
absorption, efficiency and increased bioavailability [62]. 
Buchi N. Nalluri et al in 2013, developed and evaluated mouth 
dissolving films (MDFs) of salbutamol sulfate using film former, 
hydroxypropylmethyl cellulose (HPMC) of different viscosity grades 
along with film modifier polyvinyl povidone K30 and sodium lauryl 
sulfate (SLS) by wet film applicator technique. MDFs with 13% w/w 
of HPMC E5 have shown better dissolution properties when 
compared to HPMC E15. MDFs with 0.04% w/w of SLS have 
shown superior dissolution properties as compared to MDFs 
without SLS. The film prepared using HPMC E5 and SLS showed 
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the highest dissolution rate, satisfactory in-vitro disintegration time 
and physico-mechanical properties [63]. 
 Pamula Reddy B. et al in 2013, developed and formulated 
chlorpheniramine maleate mouth dissolving films using various 
water soluble polymers such as HPMC (3cps and 5cps), methyl 
cellulose (E-15) and kollicoat IR with suitable plasticizers such as 
PEG 400 and glycerine and citric acid as saliva stimulating agent 
by solvent evaporation technique. These films were evaluated for 
thickness, folding endurance, weight variation, pH and 
disintegration time. The formulation M15 containing drug and 
kollicoat IR was considered as an optimized formulation, which 
produced 100% release of drug in 5 minutes, with phosphate buffer 
of pH 6.8 as dissolution medium [64].  
GS Khaja Nayub Rasool et al in 2014, formulated and evaluated 
oral films of Losartan potassium using different polymers such as 
PVA, PVP, HPMC, Carbopol, Pectin and Tragacanth by using 
solvent casting method. The in-vitro drug release was found to be 
78-96% within 5 min. the disintegration and dissolution rates were 
increases with increased patient compliance by avoiding first pass 
metabolism and enhanced bioavailability [65] 
Dr. D. Nagendrakumar et al im 2015, formulated and evaluated fast 
dissolving oral films of Metoprolol succinate by using HPMC E5 
and HEC polymers by solvent casting method. The optimum 
formulation has diaintegration time of 7 seconds and showed 98% 
drug release within 5 minutes.[66]  
Shaik Firoz et al in 2013 prepared and evaluated mucoadhesive 
buccal films of Pantoprazole using film forming p[olymer like 
HPMC-K100 and sodium alginate by solvent casting method. The 
drug release was found to be increased with increase in polymer 
concentration. Four formulation were prepared by this method out 
of which formulation 2 and 4 showed optimum drug release.[67] 
Rakesh Patel et al in 2013, prepared Levocetirizine dihydrochloride 
by using PVA and HPMC E15 in combination as film forming 
polymer and PEG as plasticizer to get rapid release and onset of 
action in allergic conditions. This film is prepared by using solvent 
casting method at different concentration of PVA, HPMC E15 and 
PEG. Formulation with HPMC E15: PVA (3%) and PEG (10%) 
were found to be optimum for quick disintegration and dissolution 
[68]. 
Amit E. Birari et al in 2014, developed and evaluated fast 
dissolving films of Atenolol by using solvent casting method. These 
films are prepared by using PVA, glycerine, SLS and HPMC. In this 
all concentrations were kept constant by varing concentration of 
HPMC. Formulation 2 showed good results as compared to other 
formulations with release of 99.47 % at the end of 5 min. [69]. 
Govind Shankar Pandey et al in 2014, had studied the effect of 
Maltodextrin and Glycerine on oral thin films of Salbutamol sulfate 
by using solvent casting method. Mouth dissoving films prepared 
by 55% w/w Maltodextrin and 19.99% w/w Glycerine was found to 
be optimum. Prepared film showed good results for bioavailability, 
disintegration and dissolution with good flexibility and tensile 
strength [70].  
Ramani Gade et al in 2014, designed and developed Pravastatin 
Sodium fast dissolving films from natural mucilage of Ocimum 
Bacilicum seeds. Films werw prepared by using glycerine, PEG 
400 as plasticizer, aspartame as sweetner, eugenol as flavouring 
agent, Xylitol, Mannitol and sorbitol as film modifiers. Different 
formulations were propared but formulation with PVA and Ocimum 
Bacilum mucilage powder in the ratio of (1.5%: 0.5%) was found to 
be suitable in the form of fast dissolving oral films. This formulation 
showed less disintegration time and faster release of drug [71].      
Rajesh KAZA et al in 2014, designed fast dissolving oral films of 
Valsartan by solvent casting method using different grades of 
polymer HPMC (E5, E50 and K4M). They prepared six 
formulations and evaluated. The formulation which contains HPMC 
E5 and valsartan solid dispersion with guargum at weight ratio of 
1:4 showed excellent film characteristics [72].   
Saneha S. Chauhan et al in 2012, prepared and evaluated Nicitine 
hydrogen tartarate (NHT) fast dissolving films for smoking 
cessation. Films were prepared by using 2%, 3% and 4% HPMC 
by solvent casting method. The type and concentration of polymer 
used had minimal effect on release of NHT from the film but did not 
show any effect on disintegration time [73]. 
Vedhi Desai et al in 2014, formulated and evaluated Olmesartan 
Medoxomil mouth dissolving film by different polymers using 
solvent casting method. It can be concluded that solubility of these 
films was increased by using ߚ- CD. Combination of polymer 
HPMC E15 and PVA was found to be optimum for final formulation 
[74]. 
Qingqing Chen et al in 2014, formulated and evaluated oral thin 
films containing the German cockroach Blatella germanica (Bla g2) 
allergen. In this a sublingual immunotherapy (SLIT) formulation of 
thin film has been developed for the treatment of hypersensitivity to 
the german cockroach, which could contain about 25 ug/ filmstrip 
of Bla g2 allergen, nearly 10 fold higher compared to the doses 
studied for liquid extracts. These films have good mechanical 
strength, consistent potency and high stability.[75]  
Prasanna Kumar Desu et al in 2013, formulated and evaluated fast 
dissolving films of Rizatriptan using hydroxypropyl methyl cellulose 
(HPMC cps) by solvent evaporation method. Formulation study 
shows good mechanical properties, less disintegration time and the 
drug release from the formulation was found to be good.[76] 
Venkata Anupama M et al in 2015, prepared and evaluated oral 
thin films of Desloratadine, 12 formulations were prepared by 
casting method using different concentration of polymers such as 
sodium alginate (1, 1.5, 2 w/v %) and Xanthum (0.4, 0.7 w/v %). As 
the concentration of polymer increased tensile strength and folding 
endurance were also improved with more dissolution time. Film 
formulations were also prepared using varying concentration of 
Gellan Gum (0.1, 0.3, 0.5 w/v %) and higher concentration of 
polymer showed good physical and rheological properties. 
Formulation with 1.5% sodium alginate was found to be 
optimum.[77]  
Vijay Kuchana et al in 2014, prepared and evaluated oral thin films 
of Buclizine by using solvent casting method. The oral thin films of 
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buclizine were prepared by using drug and polymer ratio of 1:1 and 
1:2. These films were prepared with an aim to have rapid onset of 
action and increased bioavailability in allergic conditions. During 
this study PVA and PEG were found to show good physiochemical 
properties as compared to other polymers.[78]  
D. Kapoor et al in 2015, prepared oral thin thin films of Leukotrine 
receptor antagonist (LTRA) such as Montelukast sodium. Thin films 
were prepared by using various film forming agents like HPMC, 
PVP, PEG-400 and glycerol as plasticizer and mannitol as filler and 
sweetner by solvent casting method. The films prepared by HPMC 
were clear, transparent and had smooth surface with improved 
dissolution rate. The in-vitro dissolution time of films prepared by 
HPMC was in the range of 25.38 to 39.12 sec. [79] 
Pradeep Kumar Jangra et al in 2014, developed fast dissolving oral 
thin films of Thiocolchicoside by using polymers such as HPMC 
(5cps and 15 cps) by solvent casting method. The formulation 
containing 300mg HPMC 15 cps was selected as best formulation 
as its disintegration and dissolution time was less and its released 
drug content was greater than other formulations. Dose of drug 
was reduced to from 4 mg to just 1 mg which was also helpful in 
reducing its adverse effect.[80] 
Sayed H Auda et al in 2014, designed and formulated fast 
dissolving films of Dextromethorphan hydrobromide. In this study, 
HPMC E15 was used as film forming polymer and crosspovidone 
(CPV), microcrystalline cellulose (MCC) were used as 
superdisintegrants which had pronounced impact on the film 
physiochemical properties as well as drug dissolution rate. The 
presence of saccharin and menthol may increase patient 
palatability. [81] 
Harsha Kathpalia et al in 2013, developed and evaluated oral films 
of Tramadol hydrochloride by using polymers like modified pea 
starch (Lycoat RS-720) and pullulan. Two plasticizers such as 
propylene glycol and sorbitol were evaluated which showed drug 
content above 98% and  drug release within 15 minutes.[82] 
Garima Bansal et al in 2013, developed oral thin films of 
Rizatriptan Benzoate by ternary complexation approach. In this 
complexation was done with β-cyclodextrin which masks the bitter 
taste of drug and HPMC E5 which enhance the stability of drug.[83] 
Kamalesh Upreti et al in 2014, formulated and evaluated mouth 
dissolving film of Paracetamol by solvent casting method. These 
films were prepared by using varying concentration of polymer 
(HPMC) and plasticizer (glycerol). In-vitro dissolution studies were 
carried out in distilled water and simulated salivary fluid (Ph 6.8) 
and strips disintegrated completely within 4 minutes. The optimized 
formulation showed 92% drug release within 30 minutes.[87]  
Evaluation parameters of fast dissolving oral films 
Thickness 
Thickness is essential to ascertain uniformity in the thickness of the 
film which is directly related to the dose accuracy in the film. It can 
be measured with the help of micrometer screw gauge or 
calibrated digital Vernier Calipers or dial gauge tester at different 5 
locations of the film. It should be between the range of 5-200 
micrometer [31, 85].                
Tack test 
Tack is the tenacity with which strip adheres to an accessory or a 
piece of paper that has been pressed into contact with the strip. 
There are eight stages of film drying process, they are: set-to-
touch, dust-free, tack-free, dry-to-touch, dry-hard, dry-through, dry-
to-recoat and dry print- free. Instruments are also available for this 
study [86].    
Tensile Strength 
 It is the maximum stress applied to a point at which strip specimen 
break. 
It is calculated by following formula: [32] 
Tensile strength ൌ   
Load at Failure ൈ  100
Strip thickness ൈ  strip width
 
Tear Resistance 
Tear resistance of plastic film or sheeting is a complex function of 
its ultimate resistance to rupture. Basically a very low rate of 
loading 51 mm (2 in)/min is employed and is designed to measure 
the force required to tear the specimen, is recorded as the tear 
resistance value in NewtonÊs (pounds- force) [87] . 
Folding Endurance Test 
It is determined by repeated folding of the film at the same place till 
the film breaks. The number of times the film folded without 
breaking is computed as the folding endurance value [88, 89] 
Moisture Uptake 
This test was carried out to check the physical stability and 
integrety of the films at high humid conditions. Film was placed in 
the desiccator containing standard solution of aluminiun chloride, 
keeping the humidity inside the desiccator at 79.55% RH. After 3 
days films were taken and weighed the percentage moisture 
absorption of the films was found [89].     
% Moisture content 
ൌ  ሺሺInitial weight – Final weightሻ
/ሺInitial weightሻ   ൈ 100ሻ 
Percentage Elongation 
when a stress is applied, a strip sample streches and this is 
referred to as strain. Strain is basically the deformation of strip 
divided by original dimension of the sample. It increases as the 
plasticizer content increases [9]. 
% Elongation ൌ   
Increase in length of strip
Initial length of strip
ൈ 100 
In-Vitro Dissolution Studies 
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it is carried out in simulated saliva solution of 900 ml of pH 6.4 
phosphate buffer using USP paddle apparatus at 37μ0.5 . 
Samples are withdrawn at regular intervals and analyzed by UV-
Visible spectrophotometer. Many times difficulty can be seen in 
dissolution test due to tendency of a film to float on a surface of 
dissolution medium when the paddle apparatus is employed [3, 4, 
90]. 
Disintegration test 
Disintegration time will vary depending on the formulation but 
typically the disintegration time varies from 5-30 sec. Disintegration 
of films requires USP disintegration apparatus. Although no official 
guidance is available for oral fast disintegrating oral films. Both 
disintegration and dissolution test were performed in triplicate 
manner [4, 91, 92].  
Stability Testing 
Accelerated stability study is done under common stress conditions 
like temperature, humidity and light. A piece of film was stored in 
an aluminium package at 25  with 50-60% humidity or at 40  at 
75% humidity for 4-24 weeks .then the content of drug was 
determined [9, 39, 93, 94]. 
Content uniformity 
 Content uniformity is determined by estimating the API content in 
an individual strip. Limit of content is 85-115% [9]. 
Elastic modulus 
It indicates the measurement of stiffness of the film. It is also 
known as youngÊs modulus. Higher the youngÊs modulus with small 
elongation, hard and brittle will be the strip.  It is represented as the 
[95]: 
Young’s modulus 
ൌ    
Force at corresponding strain
cross sectional area
   
ൈ    
1
Corresponding strain
 
Surface pH of film 
This can be determined by placing the film on the surface of 1.5% 
w/v agar gel then again placed on Ph paper whose pH range is 1-
11. The change in colour of pH paper was observed [96, 97]. 
Swelling properties 
Swelling property is determined by weighing each film sample and 
placing it in pre-weighed stainless steel wire mesh. The mesh 
containing film is submerged into 15 ml medium in a plastic 
container. Increase in the weight of film is determined at different 
time interval until a constant weight is observed. The degree of 
swelling was calculated by using following equation [4, 96, 97]:  
α ൌ  wt –  wo/w 
Where: wt= Weight of film at time t 
             wo= Weight of film at time zero   
Transparency 
The transparency of the film can be determined by using a simple 
UV spectrophotometer. Cut the film sample into rectangles and 
placed on the internal side of the spectrophotometer of the cell. 
The transmittance of the film is determined at 600 nm [4]. 
Transparency ൌ  ሺlogT600ሻ/b ൌ  െ€c 
Where: T600= Transmittance at 600 nm 
              b= Film thickness (mm) 
              c= Concentration 
Contact angle 
Contact is measured by Goniometer at room temperature. Place a 
drop of distilled water on the surface of dry film. Images of water 
droplet were recorded within 10 sec. of deposition by means of 
digital camera. The contact angle was measured on both side of 
drop and average is taken [11]. 
Drug content 
The film of area 2ï2 was cut and dissolved in distilled water. Then 
solvent ethanol and dichloromethane were added to solublize the 
polymer and remaining volume is made with distilled water upto 
100 ml in 100 ml volumetric flask. Then 1ml was withdrawn from 
the solution and diluted to 10 ml. The absorbance was observed at 
relevant wavelength and concentration was calculated. By 
correcting dilution factor, the drug content was calculated [88]. 
 
    Table 9: Marketed formulations of oral thin films 
S.NO. Product Manufacturer 
1 Triaminic Novartis Consumer Health [98]
2 Zuplenz MonoSol Rx [99]
3 Suboxone MonoSol Rx 
4 Ondissolve Labtec Pharma [100]
5 Setofilm Labtec Pharma
6 Sudafed Pfizer [101] 
7 Caffeine Hughes Medical Cooporation 
[102] 
8 Loratidine strips Hughes Medical Cooporation 
[103] 
9 Chloaseptic Prestige [104]
10 Suppress InnoZen [105]
Packaging of fast dissolving oral films  
There are number of packaging varities available for oral thin films, 
it should be selected adequately to preserve the integrity of the 
product. Criteria that must be taken into consideration during 
packaging includes need for unit dose packaging, barcode labeling, 
the content in instructions for use, child-resistant seals and senior 
friendly packaging. Material selected for packaging must have 
following characteristics: [106, 48] 
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They must be non-toxic 
They must protect the preparation from environmental conditions 
They must be FDA approved 
They must be non-reactive with the product 
They must not impart to the product taste and odours 
They must meet applicable temper resistant requirement 
Various type of packaging 
Foil, paper and plastic pouches 
It provides packaging which is temper-resistant 
It provides high degree of environmental protection 
During product filling operation a flexible pouch is formed by either 
vertical or horizontal forming, filling and sealing equipment [107] 
Single pouch or aluminum pouch 
Soluble drug delivery pouch is a peelable pouch for „quick 
dissolve‰ soluble films with high barrier properties 
Using a 2 structure combination allows for one side to be clear and 
other to use a cost effective foil lamination which has zero 
transmission of both gas and moisture 
The single dose pouch provides both product and dosage 
protection [107] 
Blister card with multiple units 
Blister container consists of two components: first, the blister 
(plastic), which is the formed cavity which holds the product and 
second, the lid stock (aluminium), which is the material that seals 
the blister [108]. 
The blister package is formed by heat softening by following 
method: 
A sheet of thermoplastic resin is softened by heating 
Softened sheet is vaccum dried into a countered mold 
Sheet is released from the mold after cooling 
Proceed to the packing station of filling machine 
Previously formed semi rigid blister is filled with the product and 
lidded with the heat sealable backing material  
Conclusion 
From above, this can be concluded that fast dissolving oral films 
have proved to be an innovative drug delivery system for all groups 
of population or patients with problem of swallowing. Fast 
dissolving oral films have proved to be beneficial whenever rapid 
onset of action is required like incase of asthmatic attack, cardiac 
heart failure and in epilepsy. Oral thin films are used as a good tool 
to increase the life cycle of the existing product by getting patent of 
same product as fast dissolving oral films. So this technology is 
growing in fast pace challenging most of the pharmaceutical 
companies to develop oral films for a wide range of active 
pharmaceutical ingredients. A lot of research work is going on and 
will be started in near future on fast dissolving oral film. However, 
for future growth point of view the fast dissolving oral films sector is 
well-positioned. It seems that the value of the overall oral thin film 
market will grow significantly. 
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